본문 바로가기 대메뉴 바로가기

건양대학교병원

 장영석 증명사진 교수님

안과 장영석 교수

망막 질환이 있는 분들의 삶의 동반자가 되어 드리겠습니다

전문분야 망막질환, 황반질환

진료시간표
의료진/진료일정 - 월,화,수,목,금,토,일로 구성된 표입니다.
오전 진료 진료 진료 진료
오후 진료 진료  
비고
  • 출장:2024-06-19~2024-06-20
  • 학회:2024-06-21~2024-06-21
  • 학회:2024-07-05~2024-07-06
  • 출장:2024-08-12~2024-08-14
  • 출장:2024-08-16~2024-08-16

학회및 출장등의 이유로 실제 진료스케줄과 차이가 있을 수 있습니다.

암센터진료

학력 및 경력

학력

  • 2007 ~ 2009 건양대학교 의과대학원 석사
  • 1998 ~ 2004 건양대학교 의과대학 학사

경력

  • 2023.07 ~ 현재 건양대학교병원 안과장 겸 안센터장
  • 2022.04 ~ 현재 건양대학교병원 안과 임상부교수
  • 2023.02 ~ 2023.12 건양대학교의료원 의생명연구원 의료기기융합센터 부센터장
  • 2021.10 ~ 2022.03 대전 새봄안과 망막전문의
  • 2019.09 ~ 2021.09 영등포 이안과 망막전문의
  • 2014.03 ~ 2019.08 건양대학교병원 안과 조교수
  • 2012.05 ~ 2014.02 김안과병원 망막 전임의
  • 2009.03 ~ 2012.04 육군 군의관(36사단 108연대 의무중대장, 육군훈련소 지구병원 안과)
  • 2004.03 ~ 2009.02 건양대학교병원 인턴, 레지던트

학회활동

  • 한국망막학회 정회원

연구업적

  • 2019.05Age-related differences in the prevalence of subtypes of Neovascular age-related macular degeneration in the first diagnosed eye. [Graefes Arch Clin Exp Ophthalmol]
  • 2019.05Age-related differences in the prevalence of subtypes of Neovascularage-related macular degeneration in the first diagnosed eye [Graefe's Archive for Clinical and Experimental Ophthalmology]
  • 2019.04Long-term incidence and timing of reactivation in patients with type 3 neovascularization after initial treatment [Graefes Arch Clin Exp Ophthalmol]
  • 2019.03Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization. [Int J Ophthalmol]
  • 2019.03Abrupt visual loss during anti-vascular endothelialgrowth factor treatment for type 3 neovascularization [Int J Ophthalmol]
  • 2019.02CHARACTERISTICS OF TYPE 3 NEOVASCULARIZATION LESIONS: Focus on the Incidence of Multifocal Lesions and the Distribution of Lesion Location [Retina]
  • 2018.12DIFFERENCE IN TREATMENT OUTCOMES ACCORDING TO OPTICAL COHERENCE TOMOGRAPHY-BASED STAGES IN TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION). [Retina]
  • 2018.12DIFFERENCE IN TREATMENT OUTCOMESACCORDING TO OPTICAL COHERENCETOMOGRAPHY?BASED STAGES IN TYPE3 NEOVASCULARIZATION (RETINALANGIOMATOUS PROLIFERATION) [RETINA]
  • 2018.11MORPHOLOGIC FEATURES ASSOCIATED WITH FIBROTIC SCARRING AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY. [Retina]
  • 2018.11Prechoroidal Cleft in Type 3 Neovascularization: Incidence, Timing, and Its Association with Visual Outcome [JOURNAL OF OPHTHALMOLOGY]
  • 2018.11MORPHOLOGIC FEATURES ASSOCIATEDWITH FIBROTIC SCARRING AFTER ANTI?VASCULAR ENDOTHELIAL GROWTHFACTOR THERAPY IN POLYPOIDALCHOROIDAL VASCULOPATHY [RETINA]
  • 2018.11Prechoroidal Cleft in Type 3 Neovascularization: Incidence, Timing, and Its Association with Visual Outcome. [J Ophthalmol]
  • 2018.10Development of Submacular Hemorrhage in Neovascular Age-related Macular Degeneration: Influence on Visual Prognosis in a Clinical Setting. [Korean J Ophthalmol]
  • 2018.08Early Recurrent Hemorrhage in Submacular Hemorrhage Secondary to Type 3 Neovascularization or Retinal Angiomatous Proliferation: Incidence and Influence on Visual Prognosis [SEMINARS IN OPHTHALMOLOGY]
  • 2018.07LONG-TERM VISUAL CHANGES IN INITIALLY STRONGER FELLOW EYES IN PATIENTS WITH UNILATERAL TYPE 3 NEOVASCULARIZATION. [Retina]
  • 2018.03Hyperpigmented spots after treatment for submacular hemorrhage secondary to polypoidal choroidal vasculopathy [Graefes Arch Clin Exp Ophthalmol]
  • 2018.03Hyperpigmented spots after treatment for submacular hemorrhage secondary to polypoidal choroidal vasculopathy [GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY]
  • 2018.01Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy [Jpn J Ophthalmol]
  • 2018.01Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy [JAPANESE JOURNAL OF OPHTHALMOLOGY]
  • 2018.01Long-Term Outcomes in Patients with Neovascular Age-Related Macular Degeneration Who Maintain Dry Macula after Three Monthly Ranibizumab Injections [SEMINARS IN OPHTHALMOLOGY]
  • 2018Long-Term Outcomes in Patients with Neovascular Age-Related Macular Degeneration Who Maintain Dry Macula after Three Monthly Ranibizumab Injections. [Semin Ophthalmol]
  • 2018Early Recurrent Hemorrhage in Submacular Hemorrhage Secondary to Type 3 Neovascularization or Retinal Angiomatous Proliferation: Incidence and Influence on Visual Prognosis. [Semin Ophthalmol]
  • 2017.12NATURAL COURSE OF PATIENTS DISCONTINUING TREATMENT FOR AGE-RELATED MACULAR DEGENERATION AND FACTORS ASSOCIATED WITH VISUAL PROGNOSIS [Retina]
  • 2017.12NATURAL COURSE OF PATIENTS DISCONTINUING TREATMENT FOR AGE-RELATED MACULAR DEGENERATION AND FACTORS ASSOCIATED WITH VISUAL PROGNOSIS [RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES]
  • 2017.08RECURRENCE IN PATIENTS WITH TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION) AFTER INTRAVITREAL RANIBIZUMAB. [Retina]
  • 2017.08RECURRENCE IN PATIENTS WITH TYPE 3 NEOVASCULARIZATION (RETINAL ANGIOMATOUS PROLIFERATION) AFTER INTRAVITREAL RANIBIZUMAB [RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES]
  • 2017.07Incidence and Timing of the First Recurrence in Neovascular Age-Related Macular Degeneration: Comparison Between Ranibizumab and Aflibercept. [J Ocul Pharmacol Ther]
  • 2017.06Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome [Korean J Ophthalmol]
  • 2017.06Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome [Korean Journal of Ophthalmology]
  • 2017.06Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes [Korean Journal of Ophthalmology]
  • 2017.06Polypoidal Choroidal Vasculopathy with Feeder Vessels: Characteristics, Fellow Eye Findings, and Long-term Treatment Outcomes [Korean J Ophthalmol]
  • 2017.05Characteristics of Submacular Hemorrhages in Age-Related Macular Degeneration [Optom Vis Sci]
  • 2017.05Characteristics of Submacular Hemorrhages in Age-Related Macular Degeneration [OPTOMETRY AND VISION SCIENCE]
  • 2017.04특발망막전막에서 유리체절제술 전후 망막층별 두께변화와 시력예후와의 관계 [대한안과학회지]
  • 2017.01Incidence and Timing of the First Recurrence in Neovascular Age-Related Macular Degeneration: Comparison Between Ranibizumab and Aflibercept [JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS]
  • 2017.01라니비주맙 치료에 반응이 제한적인 습성황반변성에서 3회 애플리버셉트 주입술의 효과 [대한안과학회지]
  • 2017라니비주맙 치료에 반응이 제한적인 습성황반변성에서 3회 애플리버셉트 주입술의 효과 [한안지]
  • 2017특발망막전막에서 유리체절제술 전후 망막층별 두께변화와 시력예후와의 관계 [한안지]
  • 2016.12Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study [BRITISH JOURNAL OF OPHTHALMOLOGY]
  • 2016.11Twelve-month outcomes of treatment using ranibizumab or aflibercept for neovascular age-related macular degeneration: a comparative study. [Graefes Arch Clin Exp Ophthalmol]
  • 2016.11Radiating hemorrhage in exudative age-related macular degeneration [JAPANESE JOURNAL OF OPHTHALMOLOGY]
  • 2016.11Twelve-month outcomes of treatment using ranibizumab or aflibercept for neovascular age-related macular degeneration: a comparative study [GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY]
  • 2016.10당뇨망막병증 환자에서 플루레신 형광안저조영술이 신기능에 미치는 영향 [대한안과학회지]
  • 2016.09Long-Term Outcome and Recurrence of Idiopathic Choroidal Neovascularization Treated with Intravitreal Bevacizumab. [J Ocul Pharmacol Ther]
  • 2016.08DIAGNOSIS OF TYPE 3 NEOVASCULARIZATION BASED ON OPTICAL COHERENCE TOMOGRAPHY IMAGES. [Retina]
  • 2016.08DIAGNOSIS OF TYPE 3 NEOVASCULARIZATION BASED ON OPTICAL COHERENCE TOMOGRAPHY IMAGES [RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES]
  • 2016.08"Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters " [Korean J Ophthalmol]
  • 2016.07Radiating hemorrhage in exudative age-related macular degeneration. [Jpn J Ophthalmol]
  • 2016.06Polypoidal choroidal vasculopathy in patients aged less than 50 years: characteristics and 6-month treatment outcome [Graefes Arch Clin Exp Ophthalmol]
  • 2016.06아플리버셉트 주사 후 발생한 비감염성 안내염 [대한안과학회지]
  • 2016.06당뇨망막병증 수술 중 과도한 레이저술 후 발생한 장액망막박리에서 전신 스테로이드 치료 2예 [대한안과학회지]
  • 2016.06Optical Coherence Tomography-based Diagnosis of Polypoidal Choroidal Vasculopathy in Korean Patients [Korean J Ophthalmol]
  • 2016.05Imaging Suprachoroidal Layer in Exudative Age-Related Macular Degeneration [Curr Eye Res]
  • 2016.05Imaging Suprachoroidal Layer in Exudative Age-Related Macular Degeneration [CURRENT EYE RESEARCH]
  • 2016.03Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study. [Br J Ophthalmol]
  • 2016.03Twelve-month outcomes of treatment using ranibizumab or aflibercept for neovascular age-related macular degeneration: a comparative study. [Graefes Arch Clin Exp Ophthalmol]
  • 2016.03Long-Term Outcomes of Anti-Vascular Endothelial Growth Factor Therapy for Polypoidal Choroidal Vasculopathy [J Ocul Pharmacol Ther]
  • 2016.02Fellow-eye neovascularization in unilateral retinal angiomatous proliferation in a Korean population [Acta Ophthalmol]
  • 2016.01Self-recognition of recurrences among patients with exudative age-related macular degeneration [Clin Exp Optom]
  • 2016.01망막혈관종성증식에 동반된 망막색소상피파열에서 항혈관내피세포성장인자 주입술의 임상결과 [대한안과학회지]
  • 2016.01Self-recognition of recurrences among patients with exudative age-related macular degeneration [CLINICAL AND EXPERIMENTAL OPTOMETRY]
  • 2016.01Long-Term Outcome and Recurrence of Idiopathic Choroidal Neovascularization Treated with Intravitreal Bevacizumab [JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS]
  • 2016스펙트럼 영역 빛간섭단층촬영을 이용한 한국인의 연령과 성별에 따른 황반부 층별 두께 연구 [대한안과학회지]
  • 2016망막혈관종성증식에 동반된 망막색소상피파열에서 항혈관내피세포성장인자 주입술의 임상결과 [대한안과학회지]
  • 2015.12PREVALENCE OF SUBTYPES OF RETICULAR PSEUDODRUSEN IN NEWLY DIAGNOSED EXUDATIVE AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY IN KOREAN PATIENTS. [Retina]
  • 2015.12PREVALENCE OF SUBTYPES OF RETICULAR PSEUDODRUSEN IN NEWLY DIAGNOSED EXUDATIVE AGE-RELATEDMACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY IN KOREAN PATIENTS [RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES]
  • 2015.12비외상성 비당뇨병성 유리체 출혈환자에서 유리체 절제술을 통한 원인 질환 분석 [대한안과학회지]
  • 2015.10Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor. [Korean J Ophthalmol]
  • 2015.10Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor [Korean Journal of Ophthalmology]
  • 2015.0814세 여아에서 발생한 다발성 소실성 흰 점 증후군 [대한안과학회지]
  • 2015.02Choroidal vascular hyperpermeability and punctate hyperfluorescent spot in choroidal neovascularization [Invest Ophthalmol Vis Sci]
  • 2015.02Choroidal Vascular Hyperpermeability and Punctate Hyperfluorescent Spot in Choroidal Neovascularization [INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE]
  • 2014.12Intravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity [Korean J Ophthalmol]
  • 2014.10Factors influencing the exudation recurrence after cataract surgery in patients previously treated with anti-vascular endothelial growth factor for exudative age-related macular degeneration. [Graefes Arch Clin Exp Ophthalmol]
  • 2014.10Factors influencing the exudation recurrence after cataract surgery in patients previously treated with anti-vascular endothelial growth factor for exudative age-related macular degeneration [GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY]
  • 2014.09당뇨황반부종 환자에서 이미지 압축이 빛간섭단층촬영 결과 해석에 미치는 영향 [대한안과학회지]
  • 2014.09당뇨황반부종 환자에서 이미지 압축이 빛간섭단층촬영 결과해석에 미치는 영향 [대한안과학회지]
  • 2014.04Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization [Ophthalmology]
  • 2014.04Intravitreal Anti-Vascular Endothelial Growth Factor for Submacular Hemorrhage from Choroidal Neovascularization [OPHTHALMOLOGY]
  • 2013.12Effects of choroidal vascular hyperpermeability on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy [Am J Ophthalmol]
  • 2008.12A case of an asymptomatic intralenticular foreign body [Korean J Ophthalmol]
  • 2008.12Effect of muscle relaxants on short-term results of exotropia surgery: a focus on resection procedures [Korean J Ophthalmol]
  • 2008.03안내충전물로서 과불화탄소액을 이용한 거대 망막열공이 동반된 망막박리 환자 치료 증례 1예 [대한안과학회지]
 장영석 교수님